HOME >> MEDICINE >> NEWS
Jefferson scientists find that drug-eluting stents are disappointing in bypass grafts -- sometimes

(PHILADELPHIA) -- While drug-eluting stents are effective in keeping open bypassed heart veins that arent too diffuse (filled with cholesterol plaque), a new study by cardiologists at Jefferson Medical College shows that they fare less well in keeping open bypassed veins with longer blockages. The researchers suggest that doctors think twice before inserting the drug-coated stents in such extensively diseased bypassed grafts.

The researchers looked at the success of drug-eluting stents in bypassed vein grafts and found that long-term success was dependent on the healthiness of the vessel. Lead researcher Nicholas J. Ruggiero II, M.D., a fellow in cardiovascular diseases, will present the results at the American College of Cardiologys 56th Annual Scientific Session on Monday, March 26, from 4 to 4:50 pm. (Abstract 916-214).

Seventy patients--61 men and nine women with a mean age of 70 years--were studied. Twenty eight (40 percent) of the patients had diabetes. The researchers divided the patients into those with focal disease (less than 30 millimeters of disease or fewer than three blockages in one vessel) or diffuse (extensive) disease (more than 30 millimeters of disease or three or more lesions in a single bypass).

Focal disease is considered to be less of a problem in the veins of patients who have undergone heart bypass surgery. Diffuse disease means that the artery is much more clogged and therefore at greater risk of re-clogging.

Thirty nine percent of the patients had diffuse disease. After one year, the researchers found that 84 percent of these patients were free of clinical restenosis (re-clogging) or disease in the drug-eluted stent bypasses. In patients with focal blockage, only three percent needed an additional procedure to treat restenosis after one year. In contrast, in patients with diffuse disease, 37 percent needed additional procedures to treat restenosis.

"To date, drug-eluting stents havent
'"/>

Contact: Nan Myers
nan.myers@jefferson.edu
215-955-6300
Thomas Jefferson University
26-Mar-2007


Page: 1 2

Related medicine news :

1. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
2. Jefferson pharmacologist says biomarker discovery bodes well for better cancer diagnostics
3. Jefferson immunology researchers show blood-brain barrier damage could affect MS severity
4. Jefferson scientists find that plavix appears to be safe during and after heart bypass
5. Treatment of in-hospital cardiac patients is focus of Jefferson University presentations
6. Empathy skills must be given a high priority in medical education, says Jefferson author
7. Natural, soy-based substance might help fight MS, Jefferson neuroscientists find
8. Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
9. Obesity tied to higher risk of complications in spinal surgery, Jefferson neurosurgeon finds
10. Jefferson Orthopaedic surgeons leading international study of timing of spinal surgery
11. Jefferson scientists find boosting protein levels staves off heart failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2020)... ... ... Dr. Katinka van der Merwe, the creator of the world’s leading 12 week ... Grace podcast. She explains her outside-the-box, holistic approach to treating CRPS and how important ... diagnosed with CRPS about 10 years ago, Amberly Lago , the host of ...
(Date:6/24/2020)... ... , ... Skyroam , the developer of patented virtual SIM (vSIM) technology ... provider of enterprise software for testing laboratories, in which its Skyroam Solis Lite 4G ... Surveillance Lab (PDSL) kit. , “Stopping the spread of COVID-19 is a global effort ...
(Date:6/23/2020)... ... June 23, 2020 , ... Anesthesia ... patients and providers alike. The virus, which is primarily found in oral, nasal, ... through respiratory droplets, contact contamination, or by aerosols produced during aerosol-generating procedures (AGPs). ...
(Date:6/23/2020)... ... 2020 , ... In its latest report on companion diagnostics , IVD ... tests tied to therapeutic selection or effectiveness. To get a sense of the ... companies serving them to determine recent market trends. The analysts found:, ...
(Date:6/23/2020)... ... 2020 , ... MemoryCare.com, a comprehensive resource for caregivers and ... in Hendersonville, Tennessee. The guide identifies 12 memory care communities based on location, ... Association, 5.6 million people age 65 and older are living with Alzheimer's dementia. ...
Breaking Medicine News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... Award-winning digital product design and development agency ... million users, to build a COVID-19 map . The goal between both companies ... through easy-to-understand data and visuals on the current COVID-19 situation both globally and locally. ...
(Date:6/19/2020)... Ariz. (PRWEB) , ... June 19, 2020 , ... With ... soon launch another Warrior Gym at in Queen Creek. Since the foundation of the ... complete freedom. In essence, all of the gym locations still share the vision of ...
(Date:6/19/2020)... ... 19, 2020 , ... The Conference Forum is pleased to announce the launch ... PODD: Partnership Opportunities in Drug Delivery conference, which features a wide range of drug ... different voices making an impact and advancing the field of drug delivery. It will ...
Breaking Medicine Technology:
Cached News: